Induced pluripotent stem cell technology for generating photoreceptors

Regenerative Medicine

Volumn 6, Issue 4, 2011, Pages 469-479

  Boucherie, Cédric ^a   Sowden, Jane C ^b   Ali, Robin R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

embryonic stem cell; eye; induced pluripotent stem cell; nuclear reprogramming; photoreceptor; regeneration; retina; retinal degeneration; retinitis pigmentosa

Indexed keywords

CONE OPSIN; DICKKOPF 1 PROTEIN; NOGGIN; NOTCH RECEPTOR; RECOVERIN; RHODOPSIN;

BIOTECHNOLOGY; BLASTOCYST; CELL DIFFERENTIATION; CELL EXPANSION; CELL FATE; CELL TRANSPLANTATION; CILIARY BODY EPITHELIUM; EMBRYONIC STEM CELL; GENE MUTATION; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PHOTORECEPTOR; PHOTORECEPTOR TRANSPLANTATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PRPH2 GENE; RETINA DEGENERATION; RETINA GANGLION CELL; RETINA NERVE CELL; RETINA ROD; REVIEW; RP9 GENE; SOMATIC CELL;

HUMANS; INDUCED PLURIPOTENT STEM CELLS; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL DEGENERATION; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION;

EID: 79960211130     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.37     Document Type: Review

References (73)

1. Bharti K, Miller SS, Arnheiter H. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res. 24(1), 21-34 (2011).
2. Resnikoff S, Pascolini D, Etyaale D, et al. Global data on visual impairment in the year 2002. Bull.World Health Organ. 82(11), 844-851 (2004). (Pubitemid 39573742)
3. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Lebers congenital amaurosis. N. Engl. J. Med. 358(21), 2231-2239 (2008). (Pubitemid 351724452)
4. MacLaren RE, Pearson RA, MacNeil A, et al. Retinal repair by transplantation of photoreceptor precursors. Nature 444(7116), 203-207 (2006). (Pubitemid 44722060)
5. West EL, Pearson RA, Tschernutter M, Sowden JC, MacLaren RE, Ali RR. Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp. Eye Res. 86(4), 601-611 (2008).
6. Pearson RA, Barber AC, West EL, et al. Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina. Cell Transplant. 19(4), 487-503 (2010).
7. Lakowski J, Baron M, Bainbridge J, et al. Cone and rod photoreceptor transplantation in models of the childhood retinopathy Leber congenital amaurosis using flow-sorted Crx-positive donor cells. Hum. Mol. Genet. 19(23), 4545-4559 (2010).
8. Lamba D, Karl M, Reh T: Neural regeneration and cell replacement: a view from the eye. Cell Stem Cell 2(6), 538-549 (2008). (Pubitemid 351729217)
9. Tropepe V, Coles BL, Chiasson BJ, et al. Retinal stem cells in the adult mammalian eye. Science 287(5460), 2032-2036 (2000). (Pubitemid 30158683)
10. Coles BL, Angenieux B, Inoue T, et al. Facile isolation and the characterization of human retinal stem cells. Proc. Natl Acad. Sci. USA 101(44), 15772-15777 (2004). (Pubitemid 39473563)
11. MacNeil A, Pearson RA, MacLaren RE, Smith AJ, Sowden JC, Ali RR. Comparative analysis of progenitor cells isolated from the iris, pars plana, and ciliary body of the adult porcine eye. Stem Cells 25(10), 2430-2438 (2007). (Pubitemid 47582735)
12. Cicero SA, Johnson D, Reyntjens S, et al. Cells previously identified as retinal stem cells are pigmented ciliary epithelial cells. Proc. Natl Acad. Sci. USA 106(16), 6685-6690 (2009).
13. Gualdoni S, Baron M, Lakowski J, et al. Adult ciliary epithelial cells, previously identified as retinal stem cells with potential for retinal repair, fail to differentiate into new rod photoreceptors. Stem Cells 28(6), 1048-1059 (2010).
14. West EL, Pearson RA, MacLaren RE, Sowden JC, Ali RR. Cell transplantation strategies for retinal repair. Prog. Brain Res. 175, 3-21 (2009).
15. Ikeda H, Osakada F, Watanabe K, et al. Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proc. Natl Acad. Sci. USA 102(32), 11331-11336 (2005). (Pubitemid 41153820)
16. Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc. Natl Acad. Sci.USA 103(34), 12769-12774 (2006). (Pubitemid 44298636)
17. Osakada F, Ikeda H, Mandai M, et al. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat. Biotechnol. 26(2), 215-224 (2008). (Pubitemid 351225958)
18. Lamba DA, Gust J, Reh TA. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell 4(1), 73-79 (2009).
19. Briggs R, King TJ. Transplantation of living nuclei from blastula cells into enucleated frogs eggs. Proc. Natl Acad. Sci. USA 38(5), 455-463 (1952).
20. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 385(6619), 810-813 (1997). (Pubitemid 27106068)
21. Gurdon JB, Byrne JA, Simonsson S. Nuclear reprogramming and stem cell creation. Proc. Natl Acad. Sci. USA 100(Suppl. 1), 11819-11822 (2003). (Pubitemid 37205889)
22. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11(19), 1553-1558 (2001). (Pubitemid 32931020)
23. Cowan CA, Atienza J, Melton DA, Eggan K: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309(5739), 1369-1373 (2005). (Pubitemid 41209363)
24. Kimura H, Tada M, Nakatsuji N, Tada T. Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol. Cell Biol. 24(13), 5710-5720 (2004). (Pubitemid 38787957)
25. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006). (Pubitemid 44233629)
26. Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1(1), 55-70 (2007).
27. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448(7151), 313-317 (2007). (Pubitemid 47080336)
28. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151), 318-324 (2007). (Pubitemid 47080337)
29. Zhang J, Wilson GF, Soerens AG, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104(4), e30-e41 (2009).
30. Boland MJ, Hazen JL, Nazor KL, et al. Adult mice generated from induced pluripotent stem cells. Nature 461(7260), 91-94 (2009).
31. Kang L, Wang J, Zhang Y, Kou Z, Gao S. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 5(2), 135-138 (2009).
32. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27(3), 275-280 (2009).
33. Carvajal-Vergara X, Sevilla A, DSouza SL, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465(7299), 808-812 (2010).
34. Lee G, Papapetrou EP, Kim H, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461(7262), 402-406 (2009).
35. Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5), 618-630 (2010).
36. Stadtfeld M, Apostolou E, Akutsu H, et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465(7295), 175-181 (2010).
37. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26(1), 101-106 (2008).
38. Brambrink T, Foreman R, Welstead GG, et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2(2), 151-159 (2008). (Pubitemid 351168714)
39. Kiskinis E , Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 120(1), 51-59 (2010).
40. Eiraku M, Takata N, Ishibashi H, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472(7341), 51-56 (2011).
41. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 282(5391), 1145-1147 (1998). (Pubitemid 28516247)
42. Watanabe K, Kamiya D, Nishiyama A, et al. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 8(3), 288-296 (2005). (Pubitemid 40300185)
43. Kubo F, Takeichi M, Nakagawa S. Wnt2b inhibits differentiation of retinal progenitor cells in the absence of Notch activity by downregulating the expression of proneural genes. Development 132(12), 2759-2770 (2005). (Pubitemid 40932866)
44. Jadhav AP, Mason HA, Cepko CL. Notch 1 inhibits photoreceptor production in the developing mammalian retina. Development 133(5), 913-923 (2006).
45. Yaron O, Farhy C, Marquardt T, Applebury M, Shery-Padan R. Notch1 functions to suppress cone-photoreceptor fate specification in the developing mouse retina. Development 133(7), 1367-1378 (2006).
46. Lamba DA, McUsic A, Hirata RK, Wang PR, Russell D, Reh TA. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One 5(1), e8763 (2010).
47. Lamba DA , Reh TA. Microarray characterization of human embryonic stem cell-derived retinal cultures. Invest. Ophthalmol. Vis. Sci. DOI: 10.1167/iovs.10-6504 (2011) (Epub ahead of print).
48. Meyer JS, Shearer RL, Capowski EE, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 106(39), 16698-16703 (2009).
49. Ali RR, Sowden JC. Regenerative medicine: DIY eye. Nature 472(7341), 42-43 (2011).
50. Hirami Y, Osakada F, Takahashi K, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci. Lett. 458(3), 126-131 (2009).
51. Osakada F, Jin ZB, Hirami Y, et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J. Cell Sci. 122(Pt 17), 3169-3179 (2009).
52. Hu BY, Weick JP, Yu J, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107(9), 4335-4340 (2010).
53. Parameswaran S, Balasubramanian S, Babai N, et al. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration. Stem Cells 28(4), 695-703 (2010).
54. Polo JM, Liu S, Figueroa ME, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28(8), 848-855 (2010).
55. Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458(7239), 766-770 (2009).
56. Li C, Zhou J, Shi G, et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum. Mol. Genet. 18(22), 4340-4349 (2009).
57. Sun N, Panetta NJ, Gupta DM, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. (37), 15720-15725 (2009).
58. Staerk J, Dawlaty MM, Gao Q, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. 7(1), 20-24 (2010).
59. Lagutin OV, Zhu CC, Kobayashi D, et al. Six3 repression of Wnt signaling in the anterior neuroectoderm is essential for vertebrate forebrain development. Genes Dev. 17(3), 368-379 (2003). (Pubitemid 36182196)
60. Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, et al. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev. Cell 1(3), 423-434 (2001). (Pubitemid 33586091)
61. Bachiller D, Klingensmith J, Kemp C, et al. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 403(6770), 658-661 (2000). (Pubitemid 30104006)
62. Pera EM, Wessely O, Li SY, De Robertis EM. Neural and head induction by insulin-like growth factor signals. Dev. Cell 1(5), 655-665 (2001). (Pubitemid 33586118)
63. Fossat N, Jones V, Khoo PL, et al. Stringent requirement of a proper level of canonical WNT signalling activity for head formation in mouse embryo. Development 38(4), 667-676 (2011).
64. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinsons disease. Proc. Natl Acad. Sci. USA 105(15), 5856-5861 (2008). (Pubitemid 351758462)
65. Hargus G, Cooper O, Deleidi M, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl Acad. Sci. USA 107(36), 15921-15926 (2010).
66. Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366(9502), 2019-2025 (2005). (Pubitemid 41773377)
67. Hanna J, Cheng AW, Saha K, et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 107(20), 9222-9227 (2010).
68. Buecker C, Chen HH, Polo JM, et al. A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell 6(6), 535-546 (2010).
69. Ebert AD, Yu J, Rose FF Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457(7227), 277-280 (2009).
70. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321(5893), 1218-1221 (2008).
71. Soldner F, Hockemeyer D, Beard C, et al. Parkinsons disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136(5), 964-977 (2009).
72. Marchetto MC, Carromeu C, Acab A, et al. A model for neural development and treatment of rett syndrome using human induced pluripotent stem cells. Cell 143(4), 527-539 (2010).
73. Jin ZB, Okamoto S, Osakada F, et al. Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS ONE 6(2), e17084 (2011).